These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 15356542)

  • 21. What the first 10,000 patients with chronic urticaria have taught me: a personal journey.
    Kaplan AP
    J Allergy Clin Immunol; 2009 Mar; 123(3):713-7. PubMed ID: 19081615
    [No Abstract]   [Full Text] [Related]  

  • 22. Observations on the mechanism of omalizumab as a steroid-sparing agent in autoimmune or chronic idiopathic urticaria and angioedema.
    Dreyfus DH
    Ann Allergy Asthma Immunol; 2008 Jun; 100(6):624-5. PubMed ID: 18592835
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of chronic autoimmune urticaria using polyvalent immunoglobulins].
    Lacour JP; Machet L; Jullien D; Chosidow O; Mathelier-Fusade P; Guillet G; Humbert P; Doutre MS; Meynadier J
    Ann Dermatol Venereol; 1998 Sep; 125(9):641-4. PubMed ID: 9805560
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic urticaria: do urticaria nonexperts implement treatment guidelines? A survey of adherence to published guidelines by nonexperts.
    Ferrer M; Jáuregui I; Bartra J; Dávila I; del Cuvillo A; Montoro J; Mullol J; Valero A; Sastre J
    Br J Dermatol; 2009 Apr; 160(4):823-7. PubMed ID: 19120332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
    Sanada S; Tanaka T; Kameyoshi Y; Hide M
    Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria.
    Perez A; Woods A; Grattan CE
    Br J Dermatol; 2010 Jan; 162(1):191-4. PubMed ID: 19903174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of autoimmune urticaria with low-dose cyclosporin A: A one-year follow-up.
    Boubouka CD; Charissi C; Kouimintzis D; Kalogeromitros D; Stavropoulos PG; Katsarou A
    Acta Derm Venereol; 2011 Jan; 91(1):50-4. PubMed ID: 21264453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-sedative antihistaminics in the treatment of chronic urticaria].
    Negro JM; Sarrió F; Miralles JC; García Sellés FJ; López Sánchez JD; Pagán Ja; Hernándéz J
    Allergol Immunopathol (Madr); 1995; 23(3):137-44. PubMed ID: 7572544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on chronic urticaria: focusing on mechanisms.
    Młynek A; Maurer M; Zalewska A
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):433-7. PubMed ID: 18769197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide.
    Bernstein JA; Garramone SM; Lower EG
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):212-4. PubMed ID: 12197581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologic therapy for urticaria.
    Negro-Alvarez JM; Carreño-Rojo A; Funes-Vera E; García-Cánovas A; Abellán-Alemán AF; Rubio del Barrio R
    Allergol Immunopathol (Madr); 1997; 25(1):36-51. PubMed ID: 9111875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria.
    Kaplan AP
    Allergy Asthma Proc; 2018 May; 39(3):184-190. PubMed ID: 29669665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The maddening itch: an approach to chronic urticaria.
    Viegas LP; Ferreira MB; Kaplan AP
    J Investig Allergol Clin Immunol; 2014; 24(1):1-5. PubMed ID: 24765875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Childhood urticaria.
    Marrouche N; Grattan C
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):485-90. PubMed ID: 22825024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urticaria.
    Amar SM; Dreskin SC
    Prim Care; 2008 Mar; 35(1):141-57, vii-viii. PubMed ID: 18206722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation.
    Serhat Inaloz H; Ozturk S; Akcali C; Kirtak N; Tarakcioglu M
    J Dermatol; 2008 May; 35(5):276-82. PubMed ID: 18477227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural anti-FcepsilonRIalpha autoantibodies isolated from healthy donors and chronic idiopathic urticaria patients reveal a restricted repertoire and autoreactivity on human basophils.
    Miescher SM; Horn MP; Pachlopnik JM; Baldi L; Vogel M; Stadler BM
    Hum Antibodies; 2001; 10(3-4):119-26. PubMed ID: 11847423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic urticaria: mechanisms and treatment.
    Fox RW
    Allergy Asthma Proc; 2001; 22(2):97-100. PubMed ID: 11332299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of omalizumab on patients with chronic urticaria: issues with the determination of autoimmune urticaria.
    Sheikh J
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):88; author reply 88-9. PubMed ID: 18254490
    [No Abstract]   [Full Text] [Related]  

  • 40. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism?
    Tedeschi A; Cottini M; Asero R
    Eur Ann Allergy Clin Immunol; 2009 Apr; 41(2):56-9. PubMed ID: 19585861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.